Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis

Jon Hanifin, S. C. Chan

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

The immunologic aberrations associated with atopic dermatitis include the paradox of reduced cell-mediated immune responses in the setting of increased cell-mediated immunity features that resemble allergic contact dermatitis. In this review, we present evidence that abnormalities in monocytes and Langerhans cells alter the function of T-helper-cell sub-populations to cause the immunologic defects associated with atopic dermatitis. Increased monocyte prostaglandin E2 production inhibits Th1 responses, accentuating interleukin (IL)-4 secretion by Th2 cells. Elevated prostaglandin E2 secretion correlates with abnormally increased cyclic adenosine monophosphate-phosphodiesterase activity in monocytes and this, along with other defective inflammatory cell responses, can be normalized in vitro by phosphodiesterase inhibitors. It appears that in addition to prostaglandin E2 IL-10 acts to regulate the balance between Th1 and Th2 functional responses accounting for many atopic features, including increased IL-4, IL-5, and IL-6 production by T cells; increased IgE synthesis; decreased interferon-γ production; and impaired cell-mediated immune responses. All of these abnormalities can be related to increased phosphodiesterase activity in atopic monocytes, and inhibition of this key enzyme appears to reverse atopic dermatitis inflammatory abnormalities in vitro and in vivo.

Original languageEnglish (US)
JournalJournal of Investigative Dermatology
Volume105
Issue number1 SUPPL.
StatePublished - 1995

Fingerprint

Lymphocytes
Phosphoric Diester Hydrolases
Atopic Dermatitis
Dinoprostone
Monocytes
Interleukin-4
Dermatitis
Phosphodiesterase Inhibitors
T-cells
Interleukin-5
Th1-Th2 Balance
Aberrations
Cyclic AMP
Interleukin-10
Th2 Cells
Interferons
Immunoglobulin E
Allergic Contact Dermatitis
Langerhans Cells
Interleukin-6

Keywords

  • Cell-mediated immunity
  • Interferon-γ
  • Langerhans cells
  • Mononuclear leukocytes

ASJC Scopus subject areas

  • Dermatology

Cite this

Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis. / Hanifin, Jon; Chan, S. C.

In: Journal of Investigative Dermatology, Vol. 105, No. 1 SUPPL., 1995.

Research output: Contribution to journalArticle

@article{b190546854b7462eb90f58efdb3b6114,
title = "Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis",
abstract = "The immunologic aberrations associated with atopic dermatitis include the paradox of reduced cell-mediated immune responses in the setting of increased cell-mediated immunity features that resemble allergic contact dermatitis. In this review, we present evidence that abnormalities in monocytes and Langerhans cells alter the function of T-helper-cell sub-populations to cause the immunologic defects associated with atopic dermatitis. Increased monocyte prostaglandin E2 production inhibits Th1 responses, accentuating interleukin (IL)-4 secretion by Th2 cells. Elevated prostaglandin E2 secretion correlates with abnormally increased cyclic adenosine monophosphate-phosphodiesterase activity in monocytes and this, along with other defective inflammatory cell responses, can be normalized in vitro by phosphodiesterase inhibitors. It appears that in addition to prostaglandin E2 IL-10 acts to regulate the balance between Th1 and Th2 functional responses accounting for many atopic features, including increased IL-4, IL-5, and IL-6 production by T cells; increased IgE synthesis; decreased interferon-γ production; and impaired cell-mediated immune responses. All of these abnormalities can be related to increased phosphodiesterase activity in atopic monocytes, and inhibition of this key enzyme appears to reverse atopic dermatitis inflammatory abnormalities in vitro and in vivo.",
keywords = "Cell-mediated immunity, Interferon-γ, Langerhans cells, Mononuclear leukocytes",
author = "Jon Hanifin and Chan, {S. C.}",
year = "1995",
language = "English (US)",
volume = "105",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "1 SUPPL.",

}

TY - JOUR

T1 - Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis

AU - Hanifin, Jon

AU - Chan, S. C.

PY - 1995

Y1 - 1995

N2 - The immunologic aberrations associated with atopic dermatitis include the paradox of reduced cell-mediated immune responses in the setting of increased cell-mediated immunity features that resemble allergic contact dermatitis. In this review, we present evidence that abnormalities in monocytes and Langerhans cells alter the function of T-helper-cell sub-populations to cause the immunologic defects associated with atopic dermatitis. Increased monocyte prostaglandin E2 production inhibits Th1 responses, accentuating interleukin (IL)-4 secretion by Th2 cells. Elevated prostaglandin E2 secretion correlates with abnormally increased cyclic adenosine monophosphate-phosphodiesterase activity in monocytes and this, along with other defective inflammatory cell responses, can be normalized in vitro by phosphodiesterase inhibitors. It appears that in addition to prostaglandin E2 IL-10 acts to regulate the balance between Th1 and Th2 functional responses accounting for many atopic features, including increased IL-4, IL-5, and IL-6 production by T cells; increased IgE synthesis; decreased interferon-γ production; and impaired cell-mediated immune responses. All of these abnormalities can be related to increased phosphodiesterase activity in atopic monocytes, and inhibition of this key enzyme appears to reverse atopic dermatitis inflammatory abnormalities in vitro and in vivo.

AB - The immunologic aberrations associated with atopic dermatitis include the paradox of reduced cell-mediated immune responses in the setting of increased cell-mediated immunity features that resemble allergic contact dermatitis. In this review, we present evidence that abnormalities in monocytes and Langerhans cells alter the function of T-helper-cell sub-populations to cause the immunologic defects associated with atopic dermatitis. Increased monocyte prostaglandin E2 production inhibits Th1 responses, accentuating interleukin (IL)-4 secretion by Th2 cells. Elevated prostaglandin E2 secretion correlates with abnormally increased cyclic adenosine monophosphate-phosphodiesterase activity in monocytes and this, along with other defective inflammatory cell responses, can be normalized in vitro by phosphodiesterase inhibitors. It appears that in addition to prostaglandin E2 IL-10 acts to regulate the balance between Th1 and Th2 functional responses accounting for many atopic features, including increased IL-4, IL-5, and IL-6 production by T cells; increased IgE synthesis; decreased interferon-γ production; and impaired cell-mediated immune responses. All of these abnormalities can be related to increased phosphodiesterase activity in atopic monocytes, and inhibition of this key enzyme appears to reverse atopic dermatitis inflammatory abnormalities in vitro and in vivo.

KW - Cell-mediated immunity

KW - Interferon-γ

KW - Langerhans cells

KW - Mononuclear leukocytes

UR - http://www.scopus.com/inward/record.url?scp=0029147508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029147508&partnerID=8YFLogxK

M3 - Article

C2 - 7616004

AN - SCOPUS:0029147508

VL - 105

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 1 SUPPL.

ER -